Tergene's R&D team have rich experience in the field of biotechnology with individual achievements. Tergene believes that their rich expertise is an asset to the company.

We have successfully developed technologies for the production of various vaccines and biosimilars. Acellular Pertussis (ACP) vaccine, Haemophilus influenzae type B (HiB) conjugated vaccine, Typhoid Vaccine, Streptokinase, Botulinum toxin A, Terinase - a thrombolytic enzyme are some of the technologies.

Vaccines currently under advanced stage of development include a multivalent pneumococcal vaccine and Meningococcal vaccine.